65 related articles for article (PubMed ID: 35257009)
1. The correlations between socioeconomic status and intrahepatic cholangiocarcinoma in the United States: a population-based study.
Zhu MX; Li Y
Transl Cancer Res; 2020 Aug; 9(8):4931-4942. PubMed ID: 35117855
[TBL] [Abstract][Full Text] [Related]
2. The impact of a history of cancer on pancreatic ductal adenocarcinoma survival.
He X; Li Y; Su T; Lai S; Wu W; Chen L; Si J; Sun L
United European Gastroenterol J; 2018 Jul; 6(6):888-894. PubMed ID: 30023066
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Distant Metastasis and Prognosis in Newly Diagnosed T1 Intrahepatic Cholangiocarcinoma.
Guo K; Lou Y; Zheng S
Biomed Res Int; 2023; 2023():6638755. PubMed ID: 36704724
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for intrahepatic cholangiocarcinoma: a propensity score-matched analysis.
Huang G; Song W; Zhang Y; Yu J; Lv Y; Liu K
Sci Rep; 2023 Jun; 13(1):10630. PubMed ID: 37391482
[TBL] [Abstract][Full Text] [Related]
5. Prognostic nomogram for cancer-specific survival in patients with intrahepatic cholangiocarcinoma after hepatectomy: A population study of 919 patients.
Huang G; Song W; Zhang Y; Ren B; Lv Y; Liu K
Front Surg; 2022; 9():1025521. PubMed ID: 36684170
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic nomograms for newly diagnosed intrahepatic cholangiocarcinoma with brain metastasis: A population-based analysis.
Liu Z; Yi J; Yang J; Zhang X; Wang L; Liu S
Exp Biol Med (Maywood); 2022 Sep; 247(18):1657-1669. PubMed ID: 35946168
[TBL] [Abstract][Full Text] [Related]
7. The Impact of a History of Different Other Cancers on the Long-Term Outcomes of Patients with Gallbladder Cancer: A Propensity Score-Adjusted, Population-Based Study.
Wang J; Zhang C; Yan D
Technol Cancer Res Treat; 2023; 22():15330338231183937. PubMed ID: 37394878
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Jeong S; Tong Y; Sha M; Gu J; Xia Q
Oncotarget; 2017 Mar; 8(10):17292-17300. PubMed ID: 28030846
[TBL] [Abstract][Full Text] [Related]
9. Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.
Mavros MN; Economopoulos KP; Alexiou VG; Pawlik TM
JAMA Surg; 2014 Jun; 149(6):565-74. PubMed ID: 24718873
[TBL] [Abstract][Full Text] [Related]
10. The Impact of a History of Different Other Cancers on the Long-Term Outcomes of Patients with Intrahepatic Cholangiocarcinoma: A Population-Based Analysis.
Chai J; Kong J; Zhu K
Biomed Res Int; 2022; 2022():3970884. PubMed ID: 35257009
[TBL] [Abstract][Full Text] [Related]
11. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
[No Abstract] [Full Text] [Related]
12. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z
BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
[TBL] [Abstract][Full Text] [Related]
14. Impact of cirrhosis on long-term survival outcomes of patients with intrahepatic cholangiocarcinoma.
Wang J; Qiu Y; Yang Y; Shen S; Zhi M; Zhang B; Wang W
Cancer Med; 2022 Oct; 11(19):3633-3642. PubMed ID: 35415945
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis.
Kim Y; Moris DP; Zhang XF; Bagante F; Spolverato G; Schmidt C; Dilhoff M; Pawlik TM
J Surg Oncol; 2017 Nov; 116(6):643-650. PubMed ID: 28608424
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
